Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Tanya Kowalski, Sarah Donoghue, Gerard de Jong & Heather G. Mack. (2022) Novel chorioretinal findings in two siblings with mucopolysaccharidosis type VI. Ophthalmic Genetics 43:5, pages 693-698.
Read now
Read now
Tanya Kowalski, Jonathan B Ruddle, Gerard de Jong & Heather G Mack. (2021) Expanding the phenotype of mucopolysaccharidosis type II retinopathy. Ophthalmic Genetics 42:5, pages 631-636.
Read now
Read now
Azam Safary, Hakimeh Moghaddas-Sani, Mostafa Akbarzadeh-Khiavi, Alireza Khabbazzi, Mohammad A. Rafi & Yadollah Omidi. (2021) Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses. Expert Opinion on Biological Therapy 21:9, pages 1181-1197.
Read now
Read now
Sean M. Gratton & Thanuja Neerukonda. (2019) Mucopolysaccharidosis Type I and Bilateral Optic Disc Edema. Neuro-Ophthalmology 43:6, pages 394-396.
Read now
Read now
A. Bruscolini, G. M. Amorelli, P. Rama, A. Lambiase, M. La Cava & A. Abbouda. (2017) Involvement of the Anterior Segment of the Eye in Patients with Mucopolysaccharidoses: A Review of Reported Cases and Updates on the Latest Diagnostic Instrumentation. Seminars in Ophthalmology 32:6, pages 707-714.
Read now
Read now
Articles from other publishers (46)
Ariel Nenninger, Gil Ben‐Shlomo, Rachel Allbaugh, Bethann Valentine, Elizabeth Snella, Jackie Jens, N. Matthew Ellinwood & Jodi Smith. (2023) Clinical and pathological characterization of ophthalmic disease in a canine model of mucopolysaccharidosis type I. Journal of Inherited Metabolic Disease 46:2, pages 348-357.
Crossref
Crossref
Faizal Z. Asumda, Jessica A. Kraker, Sarah C. Thomas, Joseph Maleszewski, Edwin M. Stone, Brendan C. Lanpher & Lisa A. Schimmenti. (2023) Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report. Therapeutic Advances in Rare Disease 4, pages 263300402211459.
Crossref
Crossref
Stefania Costi, Roberto Felice Caporali & Achille Marino. (2022) Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know. Diagnostics 13:1, pages 75.
Crossref
Crossref
Christoph Spartalis, Simon Dulz & Yevgeniya Atiskova. (2022) Bilateral penetrating keratoplasty revealed advanced glaucoma in a case of mucopolysaccharidosis type VI. Journal of Case Reports and Images in Ophthalmology 5:2, pages 11-15.
Crossref
Crossref
Surbhi Khurana, Parul Chawla Gupta, Ranjan Kumar Behera, Himanshi Singh & Jagat Ram. (2021) Corneal Cloudiness: A Presenting Feature of Mucopolysaccharidosis Type I. Indian Journal of Pediatrics 89:3, pages 291-291.
Crossref
Crossref
Eugeni Entchev, Sophie Antonelli, Virginie Mauro, Nicolas Cimbolini, Ingrid Jantzen, Aurelie Roussey, Jeanne-Marie Germain, Haoyue Zhang, Jean-Michel Luccarrini, Olivier Lacombe, Sarah P. Young, Laurence Feraille & Mireille Tallandier. (2022) MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment. Molecular Genetics and Metabolism 135:2, pages 143-153.
Crossref
Crossref
Bharti Sapra, Dhriti Mahajan, Sagar Chaudhary & Ashok Kumar Tiwary. 2022. Drug Delivery Systems for Metabolic Disorders. Drug Delivery Systems for Metabolic Disorders
371
409
.
Simon Jones & Frits A. Wijburg. 2022. Inborn Metabolic Diseases. Inborn Metabolic Diseases
765
783
.
Olivia Esteban, Miguel Angel Torralba, Susana Olivera, Mireya Martinez, Paula Montes, Sara Marco & Javier Ascaso. (2021) New correlations between ocular parameters and disease severity in Spanish patients with Gaucher’s disease Type I. PLOS ONE 16:12, pages e0260241.
Crossref
Crossref
Daniel A. Balikov, Adam Jacobson & Lev Prasov. (2021) Glaucoma Syndromes: Insights into Glaucoma Genetics and Pathogenesis from Monogenic Syndromic Disorders. Genes 12:9, pages 1403.
Crossref
Crossref
Saniye Gul Kaya, Seniz Inanc-Surer, Gulcin Cakan-Akdogan, Gulgun Oktay, Canan Asli Utine & Sibel Kalyoncu. (2021) Roles of matrix metalloproteinases in the cornea: A special focus on macular corneal dystrophy. Medicine in Drug Discovery 11, pages 100095.
Crossref
Crossref
Orlaith McGrath, Leon Au & Jane Ashworth. (2021) Management of Corneal Clouding in Patients with Mucopolysaccharidosis. Journal of Clinical Medicine 10:15, pages 3263.
Crossref
Crossref
Augusto Magalhães, Ana Maria Cunha, Rodrigo Vilares-Morgado, Elisa Leão-Teles, Esmeralda Rodrigues, Manuel Falcão, Ângela Carneiro, Jorge Breda & Fernando Falcão-Reis. (2021) Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies. Case Reports in Ophthalmological Medicine 2021, pages 1-7.
Crossref
Crossref
Martin Weber, Sang-Won Min, Tom Truong, Jeffrey Hung, Stephanie Dale, Mike Reichelt, Savita Ubhayakar, Carol Cain-Hom, Miriam Baca, Zhiyu Jiang, Qingling Li, Robert Brendza, Han Lin, Chung Kung, William F. Forrest, Cristine Quiason-Huynh, Wendy Sandoval, Buyun Chen, Yuzhong Deng, Amy Easton, Oded Foreman, Abdoulaye Sene & Baris Bingol. (2021) Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity. Scientific Reports 11:1.
Crossref
Crossref
Roberto Giugliani. 2021. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics
501
562
.
Haiyan Nan, Chanbum Park & Sungho Maeng. (2020) Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies. BioMed Research International 2020, pages 1-18.
Crossref
Crossref
Karolina M. Stepien, Anait K. Gevorkyan, Christian J. Hendriksz, Tinatin V. Lobzhanidze, Jordi Pérez-López, Govind Tol, Mireia del Toro Riera, Nato D. Vashakmadze & Christina Lampe. (2020) Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS). Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Vincenza Gragnaniello, Daniela Gueraldi, Laura Rubert, Francesca Manzoni, Chiara Cazzorla, Antonella Giuliani, Giulia Polo, Leonardo Salviati & Alberto Burlina. (2020) Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature. International Journal of Neonatal Screening 6:4, pages 85.
Crossref
Crossref
Hamid Khaledi & Michael H. Gelb. (2020) Tandem Mass Spectrometry Enzyme Assays for Multiplex Detection of 10-Mucopolysaccharidoses in Dried Blood Spots and Fibroblasts. Analytical Chemistry 92:17, pages 11721-11727.
Crossref
Crossref
Liujiang Song, Jacquelyn J. Bower, Telmo Llanga, Jacklyn H. Salmon, Matthew L. Hirsch & Brian C. Gilger. (2020) Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits. Molecular Therapy - Methods & Clinical Development 18, pages 24-32.
Crossref
Crossref
Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Natalia V. Zhurkova, Ekaterina Yu. Zakharova, Elena J. Voskobaeva, Marina A. Babaikina & Lyudmila M. Mikhaylova. (2020) Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases. Current Pediatrics 19:2, pages 132-141.
Crossref
Crossref
Min Seong Kim & In Hwan Cho. (2020) Ocular Findings in a Patient with Scheie Syndrome. Journal of the Korean Ophthalmological Society 61:6, pages 685-689.
Crossref
Crossref
Keiko Miyadera, Laura Conatser, Telmo A. Llanga, Kendall Carlin, Patricia O’Donnell, Jessica Bagel, Liujiang Song, Joanne Kurtzberg, R. Jude Samulski, Brian Gilger & Matthew L. Hirsch. (2020) Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I. Molecular Therapy 28:6, pages 1455-1463.
Crossref
Crossref
Eugeni Entchev, Ingrid Jantzen, Philippe Masson, Stephanie Bocart, Bruno Bournique, Jean-Michel Luccarini, Andre Bouchot, Olivier Lacombe, Jean-Louis Junien, Pierre Broqua & Mireille Tallandier. (2020) Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models. PLOS ONE 15:5, pages e0233032.
Crossref
Crossref
Daniela Intartaglia, Giuliana Giamundo, Elena Marrocco, Veronica Maffia, Francesco Giuseppe Salierno, Edoardo Nusco, Alessandro Fraldi, Ivan Conte & Nicolina Cristina Sorrentino. (2020) Retinal Degeneration in MPS-IIIA Mouse Model. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Livio Vitiello, Maddalena De Bernardo, Salvatore Guercio Nuzio, Claudia Mandato, Nicola Rosa & Pietro Vajro. (2020) Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other. Digestive and Liver Disease 52:1, pages 1-8.
Crossref
Crossref
Augusto Magalhães, Jorge Meira, Ana Maria Cunha, Raul Jorge Moreira, Elisa Leão-Teles, Manuel Falcão, Jorge Breda & Fernando Falcão-Reis. (2019) Fundoscopic Changes in Maroteaux-Lamy Syndrome. Case Reports in Ophthalmological Medicine 2019, pages 1-4.
Crossref
Crossref
Huey Yin Leong, Nor Azimah Abdul Azize, Hui Bein Chew, Wee Teik Keng, Meow Keong Thong, Mohd Khairul Nizam Mohd Khalid, Liang Choo Hung, Norzila Mohamed Zainudin, Azura Ramlee, Muzhirah Aisha Md Haniffa, Yusnita Yakob & Lock Hock Ngu. (2019) Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Mehmet Umut Akyol, Tord D. Alden, Hernan Amartino, Jane Ashworth, Kumar Belani, Kenneth I. Berger, Andrea Borgo, Elizabeth Braunlin, Yoshikatsu Eto, Jeffrey I. Gold, Andrea Jester, Simon A. Jones, Cengiz Karsli, William Mackenzie, Diane Ruschel Marinho, Andrew McFadyen, Jim McGill, John J. Mitchell, Joseph Muenzer, Torayuki Okuyama, Paul J. Orchard, Bob Stevens, Sophie Thomas, Robert Walker, Robert Wynn, Roberto Giugliani, Paul Harmatz, Christian Hendriksz & Maurizio Scarpa. (2019) Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Mehmet Umut Akyol, Tord D. Alden, Hernan Amartino, Jane Ashworth, Kumar Belani, Kenneth I. Berger, Andrea Borgo, Elizabeth Braunlin, Yoshikatsu Eto, Jeffrey I. Gold, Andrea Jester, Simon A. Jones, Cengiz Karsli, William Mackenzie, Diane Ruschel Marinho, Andrew McFadyen, Jim McGill, John J. Mitchell, Joseph Muenzer, Torayuki Okuyama, Paul J. Orchard, Bob Stevens, Sophie Thomas, Robert Walker, Robert Wynn, Roberto Giugliani, Paul Harmatz, Christian Hendriksz & Maurizio Scarpa. (2019) Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Shizuka Tomatsu, Susanne Pitz & Ulrike Hampel. (2019) Ophthalmological Findings in Mucopolysaccharidoses. Journal of Clinical Medicine 8:9, pages 1467.
Crossref
Crossref
Iskren Menkovic, Pamela Lavoie, Michel Boutin & Christiane Auray-Blais. (2019) Distribution of heparan sulfate and dermatan sulfate in mucopolysaccharidosis type II mouse tissues pre- and post-enzyme-replacement therapy determined by UPLC–MS/MS. Bioanalysis 11:8, pages 727-740.
Crossref
Crossref
Krishanthy Sornalingam, Ahmed Javed, Tariq Aslam, Panagiotis Sergouniotis, Simon Jones, Arunabha Ghosh & Jane Ashworth. (2019) Variability in the ocular phenotype in mucopolysaccharidosis. British Journal of Ophthalmology 103:4, pages 504-510.
Crossref
Crossref
Hsu-Ying Lin, You-Hsin Huang, Shao-Yu Lei, Lee-Jen Chen & Shuan-Pei Lin. (2019) Clinical ocular manifestations of Taiwanese patients with mucopolysaccharidoses VI (Maroteaux–Lamy syndrome). Taiwan Journal of Ophthalmology 9:3, pages 194.
Crossref
Crossref
Sergio Claudio Saccà, Carlo Alberto Cutolo & Tommaso Rossi. 2019. Handbook of Nutrition, Diet, and the Eye. Handbook of Nutrition, Diet, and the Eye
167
187
.
Daniela Concolino, Federica Deodato & Rossella Parini. (2018) Enzyme replacement therapy: efficacy and limitations. Italian Journal of Pediatrics 44:S2.
Crossref
Crossref
Alessandra Del Longo, Elena Piozzi & Fiammetta Schweizer. (2018) Ocular features in mucopolysaccharidosis: diagnosis and treatment. Italian Journal of Pediatrics 44:S2.
Crossref
Crossref
Miriam Rigoldi, Elena Verrecchia, Raffaele Manna & Maria Teresa Mascia. (2018) Clinical hints to diagnosis of attenuated forms of Mucopolysaccharidoses. Italian Journal of Pediatrics 44:S2.
Crossref
Crossref
Torge-Christian Wittke, Jörg Schmidtke & Lorenz Grigull. (2018) Rare diseases and sports: A pilot project to improve physical activity in patients with mucopolysaccharidosis. Translational Sports Medicine 1:5, pages 184-190.
Crossref
Crossref
Peng Pan, Mu Chen, Zhiling Zhang, Amauri Dalla Corte, Carolina Souza, Roberto Giugliani, Luying Pan, Yongchang Qiu, Lakshmi Amaravadi & Jiang Wu. (2018) A novel LC–MS/MS assay to quantify dermatan sulfate in cerebrospinal fluid as a biomarker for mucopolysaccharidosis II. Bioanalysis 10:11, pages 825-838.
Crossref
Crossref
Rebecca Ahrens-Nicklas, Lars Schlotawa, Andrea Ballabio, Nicola Brunetti-Pierri, Mauricio De Castro, Thomas Dierks, Florian Eichler, Can Ficicioglu, Alan Finglas, Jutta Gaertner, Brian Kirmse, Joerg Klepper, Marcus Lee, Amber Olsen, Giancarlo Parenti, Arastoo Vossough, Adeline Vanderver & Laura A. Adang. (2018) Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement. Molecular Genetics and Metabolism 123:3, pages 337-346.
Crossref
Crossref
Vahid Reza Yassaee, Feyzollah Hashemi-Gorji, Mohammad Miryounesi, Alireza Rezayi, Zeinab Ravesh, Fakhrolmolouk Yassaee & Shadab Salehpour. (2017) Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series. Clinica Chimica Acta 474, pages 88-95.
Crossref
Crossref
G. Chalès & P. Guggenbuhl. (2017) Mucopolisacaridosis y oligosacaridosis: manifestaciones osteoarticulares. EMC - Aparato Locomotor 50:3, pages 1-9.
Crossref
Crossref
Dipika V Patel. (2017) Systemic associations of corneal deposits: a review and photographic guide. Clinical & Experimental Ophthalmology 45:1, pages 14-23.
Crossref
Crossref
Ahmed Javed, Tariq Aslam & Jane Ashworth. (2016) Use of new imaging in detecting and monitoring ocular manifestations of the mucopolysaccharidoses. Acta Ophthalmologica 94:8, pages e676-e682.
Crossref
Crossref
Simon Jones & Frits A. Wijburg. 2016. Inborn Metabolic Diseases. Inborn Metabolic Diseases
577
590
.